HighPoint Advisor Group’s Axonics, Inc. Common Stock AXNX Stock Holding History

HighPoint Advisor Group’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,378	Closed	-$378K	–	741
2024 Q3	$378K	Hold	5,378	–	–	0.02%	423
2024 Q2	$368K	Sell	5,378 -100	-2%	-$6.74K	0.02%	417
2024 Q1	$369K	Sell	5,478 -3,400	-38%	-$229K	0.03%	417
2023 Q4	$610K	Buy	+8,878	New	+$497K	0.04%	314
2022 Q2	$1.11M	Buy	+17,660	New	+$968K	0.12%	136
2021 Q3	$1.32M	Sell	20,345 -50	-0.2%	-$3.41K	0.13%	131
2021 Q2	$1.29M	Sell	20,395 -1,000	-5%	-$59K	0.13%	134
2021 Q1	$1.29M	Sell	21,395 -4,907	-19%	-$267K	0.15%	120
2020 Q4	$1.44M	Buy	+26,302	New	+$1.23M	0.18%	113

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HighPoint Advisor Group's AXNX Position: Q4 2024 in Review

HighPoint Advisor Group sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 5,378 shares — an estimated $378K sold.

HighPoint Advisor Group first reported a position in AXNX in Q4 2020 and held it in 9 quarters. The position peaked at $1.44M in Q4 2020. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

HighPoint Advisor Group reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
HighPoint Advisor Group sold 5,378 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $378K.
HighPoint Advisor Group first reported a position in Axonics, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
HighPoint Advisor Group's Axonics, Inc. Common Stock position peaked at $1.44M in Q4 2020.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on HighPoint Advisor Group's 13F filing for Q4 2024, filed 12 Feb 2025.